Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,717 public trials 2,164 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, not recruiting

Oxalate Formation From Ascorbic Acid

NCT04603898

Conditions
Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View Trial Details
Active, not recruiting

Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)

NCT06465576

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Department of Pediatric and Adolescent Medicine, Aalborg University Hospital Aalborg, Denmark
  • Department of Pediatric and Adolescent Medicine, Aarhus University Hospital Aarhus, Aarhus N, Denmark
  • Department of Pediatric and Adolescent medicine, Esbjerg Hospital Esbjerg, Denmark
  • Department of Pediatric and Adolescent Medicine, Gødstrup Hospital Herning, Denmark
View Trial Details
Active, not recruiting

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05789069

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • New Experimental Therapeutics of Virginia - NEXT Oncology Fairfax, Virginia, United States
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, Italy
View Trial Details
Active, not recruiting

CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

NCT04322955

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • The Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University Irving Medical Center New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Active, not recruiting

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

NCT04960709

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Research Site Orange, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 196 locations
View Trial Details
Active, not recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

NCT03132922

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Washington University St Louis, Missouri, United States
View Trial Details

Related conditions